$27.09
0.752.85%
Comments
Loading...
Latest Beam Therapeutics Stock News | NASDAQ:BEAM | Benzinga
Get the latest news on Beam Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Beam Therapeutics performance
Categories: All
Friday, February 28, 2025
Thursday, February 27, 2025
Wednesday, February 26, 2025
Tuesday, February 25, 2025
Saturday, February 22, 2025
Saturday, February 15, 2025
Friday, February 14, 2025
Monday, February 03, 2025
Friday, January 31, 2025
Wednesday, January 29, 2025
Thursday, January 23, 2025
Monday, January 13, 2025
Monday, December 09, 2024
Saturday, December 07, 2024
Friday, December 06, 2024
Wednesday, November 27, 2024
Monday, November 25, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
Tuesday, November 05, 2024
- Gene Therapy Developer Beam Therapeutics Reports One Patient Death In Early-Stage Sickle Cell Disease Trial
- Beam Therapeutics To Present Hematology Franc...
- Beam Therapeutics shares are trading lower in...
- Patient In Beam Therapeutics' CRISPR Trial Fo...
- Beam Therapeutics Ended Third Quarter 2024 Wi...
- Beam Therapeutics Q3 2024 GAAP EPS $(1.77) Mi...